Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health

Comorbidity after allogeneic hematopoietic stem cell transplantation (alloHSCT) impairs quality of life (QoL), physical functioning, and survival. We developed a new standardized measure to capture comorbidity after transplantation, the Post-transplant Multimorbidity Index (PTMI) in a cohort of 50 l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff, Daniel, Herzberg, Philipp Y., Herrmann, Anne, Pavletic, Steven Z., Heussner, Pia, Mumm, Friederike, Höfer, Christina, Hilgendorf, Inken, Hemmati, Philipp G., Holler, Ernst, Greinix, Hildegard, Mitchell, Sandra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376641/
https://www.ncbi.nlm.nih.gov/pubmed/32737446
http://dx.doi.org/10.1038/s41409-020-01017-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376641/
https://www.ncbi.nlm.nih.gov/pubmed/32737446
http://dx.doi.org/10.1038/s41409-020-01017-8

Ejemplares similares